CA-125
Selected indexed studies
- The Role of CA-125 in the Management of Ovarian Cancer: A Systematic Review. (Cancer Rep (Hoboken), 2025) [PMID:40067023]
- CA 125 for surgico-pathological stage 1 endometrial cancer. (J Chin Med Assoc, 2024) [PMID:38380933]
- CA 125--epitopes and molecular size. (Int J Biol Markers, 1998) [PMID:10228900]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- The Role of CA-125 in the Management of Ovarian Cancer: A Systematic Review. (2025) pubmed
- CA 125 for surgico-pathological stage 1 endometrial cancer. (2024) pubmed
- CA 125--epitopes and molecular size. (1998) pubmed
- CA 125 in benign gynecological conditions. (1998) pubmed
- CA 125 and TB. (2021) pubmed
- [CA-125 antigen]. (2002) pubmed
- Elevated CA-125 in IgG4 mesenteritis: a red herring or a disease biomarker? Case report and literature review. (2019) pubmed
- Preoperative CA-125 in low-grade endometrial cancer: risk stratification and implications for treatment. (2019) pubmed
- More than 15 years of CA 125: what is known about the antigen, its structure and its function. (1998) pubmed
- Tumour biomarkers in heart failure: is there a role for CA-125? (2011) pubmed